VS-5584

DB12986InvestigationalSmall molecule

VS-5584 has been used in trials studying the treatment of Lymphoma, Metastatic Cancer, and Non Hematologic Cancers.

Mechanism: Pharmacologically active on Serine/threonine-protein kinase mTOR
Curator reviewed
Formula / weight: C₁₇H₂₂N₈O · 354.418 g/mol (avg)
Code names: VS-5584

Resolves to

Compound

Structure

InChIKeyQYBGBLQCOOISAR-UHFFFAOYSA-NSMILESCC(C)N1C(C)=NC2=C(N=C(N=C12)N1CCOCC1)C1=CN=C(N)N=C1

Targets

What you can answer from here — as of June 15, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

9+ReferencesStructured and connected to the statements they support

Which drugs share a target with VS-5584, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.